MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202441005734 A) filed by Dr. Reddy's Laboratories Limited, Hyderabad, Telangana, on Jan. 29, 2024, for 'improved pharmaceutical compositions of abiraterone.'
Inventor(s) include Panigrahi Dhananjay; Saka Raju; Venugopal Hariharan; Choudhury Anup Avijit; and Naidu Venkat Ramana.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a stable pharmaceutical composition of abiraterone or pharmaceutically acceptable salt thereof. Specifically, it relates to a stable pharmaceutical composition comprising a nanosuspension of abiraterone or pharmaceutically acceptable salt thereof that reduces the dose, lessen the pill burden, enhance the bioavailability of abiraterone in fasting conditions and reduce the food effect as compared to commercial products. A method of preparation of the said composition is also disclosed. Additionally, the invention pertains to the methods of treating certain cancers in mammalian subjects using the said composition."
Disclaimer: Curated by HT Syndication.
